REVOLUTION MEDICINES INC and SUMMIT THERAPEUTICS INC shares rose on Monday after experimental cancer drugs improved patient survival in late-stage trials. Revolution's pancreatic cancer pill doubled survival rates, while Summit's lung cancer therapy increased life expectancy by 15%. The clinical wins drove investor interest in advanced-stage cancer treatments.

Revolution Medicines Targets Pancreatic Cancer